Bahrain vs Central and Southern Asia: Proportion of the target population who received a 3rd dose of
Bahrain
99.0%
in 2024
Central and Southern Asia
89.0%
in 2024
Bahrain rank
1st
Central and Southern Asia rank
2nd
Proportion of the target population who received a 3rd dose of over time
- Bahrain
- Central and Southern Asia
How they compare
Bahrain currently reports 99.0% against 89.0% in Central and Southern Asia, a difference of 10.0%.
That makes Bahrain's figure about 1.1 times Central and Southern Asia's.
Across all 13 years both countries report, Bahrain has been ahead every year.
Bahrain ranks 1st and Central and Southern Asia ranks 2nd of 157 countries.
Bahrain has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Central and Southern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.1% | 20.8% | 77.4% | Bahrain |
| 2020s | 98.8% | 65.4% | 33.4% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Bahrain or Central and Southern Asia?
- Bahrain, at 99.0% against 89.0% in Central and Southern Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Bahrain and Central and Southern Asia?
- 10.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Central and Southern Asia?
- 13 years are reported by both, from 2012 to 2024.
- How do Bahrain and Central and Southern Asia rank globally for proportion of the target population who received a 3rd dose of?
- Bahrain ranks 1st and Central and Southern Asia ranks 2nd of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.